Individualized 3D-printed applicators for magnetic resonance imaging-guided brachytherapy in nasal vestibule cancer
Physics and Imaging in Radiation Oncology · 2024-07 · 31 · 100629
DOI: 10.1016/j.phro.2024.100629 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physics and Imaging in Radiation Oncology, 2024-07. Verfasst von Mischa de Ridder und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, UMC Utrecht, Utrecht, the Netherlands. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and purpose: Brachytherapy is treatment of choice for early stage nasal vestibule cancer. Over the years improvements were achieved by means of image guided target definition, interstitial implant techniques and also individual mold techniques. The aim of this study was to improve the technique of the implant so that the need for interstitial catheters can be limited by making use of patient individualized 3D-printed applicators. Materials and Methods: In 19 patients 3D-printed applicators were used to deliver pulse dose rate (PDR) brachytherapy. All patients underwent computed tomography (CT) and magnetic resonance imaging (MRI). A pre-plan with tumor delineation and manually optimized catheter positions to achieve tumor coverage was made. Based on the pre-plan a 3D-printed applicator was manufactured. Dose was evaluated by several indices: Conformity Index, Healthy Tissues Conformity Index, Dose Homogeneity Index, Dose non-uniformity ratio, Conformal index and high dose (HD) index.
Results
A high target coverage was achieved, with a median V100%CTV of 99.1 % (range, 81.8-100 %) and median CI of 0.99 (range, 0.82-1.00), as well as a median V0.7GyGTV of 100 % (range, 93.0-100 %). The median HD was 0.39 (range, 0.20-0.83). Interstitial catheters were needed in 12 patients. None of the patients developed grade ≥ II toxicity within the median follow up of 18 months.
Conclusions
This study shows that using 3D-printed applicators limits the need for interstitial catheters and also limits the high doses in normal tissue.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, UMC Utrecht, Utrecht, the Netherlands.
- Department of Head and Neck Surgical Oncology, UMC Utrecht, Utrecht, the Netherlands.
Zitieren
APA
de Ridder, M., Smolic, M., Kastelijns, M., Kloosterman, S., van der Vegt, S., Rijken, J. A., Jürgenliemk-Schulz, I. M., Dehnad, H., Kroon, P. S., & Moerland, M. A. (2024). Individualized 3D-printed applicators for magnetic resonance imaging-guided brachytherapy in nasal vestibule cancer. Physics and Imaging in Radiation Oncology, 31, 100629. https://doi.org/10.1016/j.phro.2024.100629
Vancouver
de Ridder M, Smolic M, Kastelijns M, Kloosterman S, van der Vegt S, Rijken JA, et al. Individualized 3D-printed applicators for magnetic resonance imaging-guided brachytherapy in nasal vestibule cancer. Physics and Imaging in Radiation Oncology. 2024;31:100629. doi:10.1016/j.phro.2024.100629
BibTeX
@article{deRidder2024,
author = {de Ridder, Mischa and Smolic, Milena and Kastelijns, Maarten and Kloosterman, Samantha and van der Vegt, Stefan and Rijken, Johannes A and Jürgenliemk-Schulz, Ina M and Dehnad, Homan and Kroon, Petra S and Moerland, Marinus A},
title = {Individualized 3D-printed applicators for magnetic resonance imaging-guided brachytherapy in nasal vestibule cancer},
journal = {Physics and Imaging in Radiation Oncology},
year = {2024},
volume = {31},
pages = {100629},
doi = {10.1016/j.phro.2024.100629}
}
EUVIMED